Carregant...

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors

BACKGROUND: Ursolic acid is a promising anticancer agent. The current study aims to evaluate the single- and multiple-dose pharmacokinetics (PK) as well as the safety of ursolic acid nanoliposomes (UANL) in healthy volunteers and in patients with advanced solid tumors. METHODS: Twenty-four healthy v...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhu, Zhongling, Qian, Zhengzi, Yan, Zhao, Zhao, Cuicui, Wang, Huaqing, Ying, Guoguang
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3540956/
https://ncbi.nlm.nih.gov/pubmed/23319864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S38271
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!